Variable | Baseline before treatment | 12 weeks after treatment | ||||||
---|---|---|---|---|---|---|---|---|
N | GM-epg | 95% CI | P-values | N | GM-epg | 95% CI | P-values | |
Overall | 555 | 174.21 | 154.14–196.87 | 212 | 39.88 | 36.77–43.25 | ||
Sex | ||||||||
Female | 241 | 130.36 | 110.60–153.66 | 0.0001* | 119 | 128.19 | 99.33–165.43 | 0.01 |
Male | 314 | 217.41 | 183.01–258.29 | 93 | 222.37 | 168.53–293.41 | ||
Age group | ||||||||
21–30 | 241 | 198.67 | 163.49–241.42 | 0.25** | 92 | 37.53 | 33.07–42.58 | 0.36** |
31–40 | 177 | 156.18 | 126.12–193.41 | 74 | 43.95 | 38.14–50.66 | ||
41–50 | 84 | 164.09 | 125.66–214.26 | 25 | 33.63 | 28.48–39.71 | ||
51–60 | 53 | 152.13 | 98.56–234.79 | 21 | 45.30 | 33.83–60.66 | ||
Occupation | ||||||||
Small-scale business | 66 | 136.05 | 99.65–185.74 | 0.08** | 27 | 35.81 | 28.97–44.26 | 0.89** |
Farming | 376 | 157.92 | 135.73–183.74 | 141 | 39.58 | 35.71–43.88 | ||
Fishing | 113 | 278.74 | 214.63–362.00 | 44 | 43.65 | 36.72-51.88 | ||
Village of residence | ||||||||
Igombe | 112 | 139.77 | 109.22–178.86 | 0.09** | 45 | 36.28 | 31.16–42.24 | 0.38** |
Igalagala | 98 | 215.61 | 158.21–293.83 | 45 | 42.51 | 35.35–51.12 | ||
Kayenze | 219 | 197.91 | 162.96–240.35 | 78 | 41.12 | 35.58–47.52 | ||
Sangabuye | 126 | 144.04 | 110.22–188.24 | 44 | 38.99 | 32.51–46.76 | ||
Time of residence (years) | ||||||||
3–5 | 97 | 188.36 | 142.36–249.22 | 0.43** | 33 | 43.18 | 34.74–53.67 | 0.66** |
6–10 | 83 | 156.69 | 113.85–215.65 | 30 | 35.88 | 29.56–43.54 | ||
11–20 | 136 | 204.77 | 159.53–262.83 | 52 | 41.16 | 35.20–48.14 | ||
≥21 | 239 | 159.82 | 132.07–193.39 | 97 | 39.44 | 34.68–44.84 | ||
HIV-1 serostatus | ||||||||
Negative | 526 | 175.06 | 154.48–198.39 | 0.56* | 197 | 39.88 | 36.69–43.35 | 0.22* |
Positive | 29 | 159.39 | 86.09–295.14 | 15 | 39.85 | 27.20–58.41 | ||
CD4 + count levels (cells/μL) | ||||||||
<350 | 17 | 134.59 | 52.19–347.07 | 0.75* | 11 | 49.66 | 27.16–90.79 | 0.16* |
>350 | 12 | 215.78 | 80.79–576.36 | 4 | 31.59 | 13.18–75.69 | ||
Schistosoma mansoni infection intensities (epg) | ||||||||
Light (1–100 epg) | 234 | 44.43 | 41.36–47.72 | 0.0001** | 92 | 30.89 | 28.49–33.49 | 0.0001** |
Moderate (101–399 epg | 162 | 199.39 | 188.32–211.12 | 56 | 42.85 | 37.47–49.01 | ||
Heavy (≥400 epg) | 159 | 1124.33 | 987.62–1277.36 | 64 | 54.07 | 44.81–65.25 |